Thu, Dec 25, 2014, 5:50 AM EST - U.S. Markets closed for Christmas

Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • rx7171 rx7171 Dec 13, 2012 1:26 AM Flag

    Hydrogel news, scaffolding trial

    As I recall they had submitted to the FDA an outline of a Phase I program with hydrogel in peripheral nervous system and were waiting for the inevitable suggestions from the FDA on how they want it changed.
    Then NVIV resubmits based on suggested changes and probably gets it back with more suggestions.
    Eventually NVIV will submit a program in great detail for the FDA to ok for a Phase I trial.
    Even though the submittal has been reviewed and tailored to the FDA's requirements it almost seems like they then treat it as new to them and then goes through a thorough review.
    This has been going on for number of months so maybe we'll hear something this spring.

    I may be confusing this with the spinal hydrogel program but I suspect we won't get anything from FDA on it until the scaffold program is given go ahead for Phase I.

    Sentiment: Buy

 
NVIV
1.39+0.08(+6.11%)Dec 24 12:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yahoo! Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Noble Energy, Inc.
NYSEWed, Dec 24, 2014 2:48 PM EST